JACC. Heart failure最新文献

筛选
英文 中文
Cardiac Structure and Function in Women After Preeclampsia 子痫前期妇女心脏结构和功能的变化
IF 13 1区 医学
JACC. Heart failure Pub Date : 2026-10-23 DOI: 10.1016/j.jchf.2026.103421
Jessica V. Yao, Benjamen Wang, Camryn Wong, Andrew Browne, Stacey Peters, Andrew Taylor, Shaun Brennecke, Ingrid Winship, Dominica Zentner
{"title":"Cardiac Structure and Function in Women After Preeclampsia","authors":"Jessica V. Yao, Benjamen Wang, Camryn Wong, Andrew Browne, Stacey Peters, Andrew Taylor, Shaun Brennecke, Ingrid Winship, Dominica Zentner","doi":"10.1016/j.jchf.2026.103421","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103421","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"15 1","pages":""},"PeriodicalIF":13.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149231558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment and Reversibility of Hepatic Abnormalities in Heart Failure 心力衰竭患者肝脏异常的评估和可逆性
IF 13 1区 医学
JACC. Heart failure Pub Date : 2026-10-23 DOI: 10.1016/j.jchf.2026.103433
Jordan S. Sack, Muhammad Shahzeb Khan, Helen S. Te
{"title":"Assessment and Reversibility of Hepatic Abnormalities in Heart Failure","authors":"Jordan S. Sack, Muhammad Shahzeb Khan, Helen S. Te","doi":"10.1016/j.jchf.2026.103433","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103433","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"5 1","pages":""},"PeriodicalIF":13.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149232876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A REBIRTH of Disease-Specific Therapy 疾病特异性治疗的重生
IF 13 1区 医学
JACC. Heart failure Pub Date : 2026-10-22 DOI: 10.1016/j.jchf.2026.103418
Chinelo L. Onyilofor, Melinda B. Davis, Michael C. Honigberg
{"title":"A REBIRTH of Disease-Specific Therapy","authors":"Chinelo L. Onyilofor, Melinda B. Davis, Michael C. Honigberg","doi":"10.1016/j.jchf.2026.103418","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103418","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 1","pages":""},"PeriodicalIF":13.0,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149231575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bromocriptine for Myocardial Recovery in Peripartum Cardiomyopathy 溴隐亭对围产期心肌病心肌恢复的作用
IF 13 1区 医学
JACC. Heart failure Pub Date : 2026-10-22 DOI: 10.1016/j.jchf.2026.103376
Tianxiu Wang, Andrea J. Ibarra, Donna Simpson, Jill Kirsch, Agnes Koczo, Joan E. Briller, Kaleab Z. Abebe, Dennis McNamara, Michael M. Givertz
{"title":"Bromocriptine for Myocardial Recovery in Peripartum Cardiomyopathy","authors":"Tianxiu Wang, Andrea J. Ibarra, Donna Simpson, Jill Kirsch, Agnes Koczo, Joan E. Briller, Kaleab Z. Abebe, Dennis McNamara, Michael M. Givertz","doi":"10.1016/j.jchf.2026.103376","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103376","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"24 1","pages":""},"PeriodicalIF":13.0,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149231574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Safety and Procedural Performance of an Interatrial Shunt for Heart Failure According to Ejection Fraction. 根据射血分数评价心房分流治疗心力衰竭的长期安全性和手术性能。
IF 11.9 1区 医学
JACC. Heart failure Pub Date : 2026-10-13 DOI: 10.1016/j.jchf.2026.103375
Josep Rodés-Cabau, Gregg W Stone, Saibal Kar, Stefan Verheye, Ariel Roguin, Jeroen Bax, Antoni Bayes-Genis, Julio Nunez, Jeremiah Depta, Michal Laufer-Perl, Gil Moravsky, Alicia Romero, Edgard Prihadi, Eugene S Chung, Matthew J Price, Michael Chenier, Dimitry Schewel, Sachin Kumar, Stephan Kische, Kunjan Bhatt, Kevin S Shah, Daniel J Donovan, Suzanne Hendrix, Patrick O'Keefe, William T Abraham, Michael R Zile, Stefan D Anker, Neal L Eigler, JoAnn Lindenfeld
{"title":"Long-Term Safety and Procedural Performance of an Interatrial Shunt for Heart Failure According to Ejection Fraction.","authors":"Josep Rodés-Cabau, Gregg W Stone, Saibal Kar, Stefan Verheye, Ariel Roguin, Jeroen Bax, Antoni Bayes-Genis, Julio Nunez, Jeremiah Depta, Michal Laufer-Perl, Gil Moravsky, Alicia Romero, Edgard Prihadi, Eugene S Chung, Matthew J Price, Michael Chenier, Dimitry Schewel, Sachin Kumar, Stephan Kische, Kunjan Bhatt, Kevin S Shah, Daniel J Donovan, Suzanne Hendrix, Patrick O'Keefe, William T Abraham, Michael R Zile, Stefan D Anker, Neal L Eigler, JoAnn Lindenfeld","doi":"10.1016/j.jchf.2026.103375","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103375","url":null,"abstract":"<p><strong>Background: </strong>Long-term device durability and phenotype-specific safety outcomes after interatrial shunting require further characterization.</p><p><strong>Objectives: </strong>This study aimed to evaluate the procedural success, device durability, and heart failure (HF) phenotype-specific safety outcomes of an interatrial shunt in the RELIEVE-HF trial.</p><p><strong>Methods: </strong>Randomized patients were assigned 1:1 to shunt or sham control with prespecified stratification by left ventricular ejection fraction (LVEF) into heart failure with reduced ejection fraction (HFrEF) (LVEF ≤40%) and heart failure with preserved ejection fraction (HFpEF) (LVEF >40%). Procedural performance, device durability, serious adverse events (SAEs), major adverse cardiovascular or neurological events (MACNE), major bleeding, and renal outcomes were assessed through 2 years.</p><p><strong>Results: </strong>Among 605 enrolled patients (508 randomized; 97 roll-in), shunt implantation was attempted in 370 and was successful in 369 (99.7%). Among implanted patients with follow-up (n = 348), no device- or procedure-related MACNE occurred through 2 years (0%; 95% CI: 0%-0.9%), and shunt patency was 99.4% (95% CI: 97.9%-99.9%). Prespecified LVEF-stratified analyses demonstrated divergent safety profiles. In HFrEF, shunt therapy was not associated with excess all-cause MACNE, major bleeding, or renal decline and was associated with lower SAE burden. In HFpEF, shunt therapy was associated with higher all-cause MACNE, greater SAE burden, increased major bleeding, and greater renal decline.</p><p><strong>Conclusions: </strong>Interatrial shunt implantation was mechanically reliable and durable through 2 years. Safety outcomes differed by HF phenotype, with no evidence of excess clinical safety events in HFrEF but increased adverse events in HFpEF. These findings support phenotype-specific evaluation of interatrial shunt therapy. (REducing Lung congestion symptoms using the v-wavE shunt in adVancEd Heart Failure [RELIEVE-HF]; NCT03499236).</p>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":"103375"},"PeriodicalIF":11.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149193720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of Serum Transthyretin to NT-proBNP Ratio in Transthyretin Amyloid Cardiomyopathy: Insights From ATTRibute-CM. 血清转甲状腺素与NT-proBNP比值在转甲状腺素淀粉样心肌病中的意义:来自属性- cm的见解。
IF 11.9 1区 医学
JACC. Heart failure Pub Date : 2026-10-11 DOI: 10.1016/j.jchf.2026.103493
Peder L Myhre, Gillian Murtagh, Hanna K Gaggin, Prem Soman, Mazen Hanna, Daniel P Judge, Ahmad Masri, Michel G Khouri, Emer Joyce, Kevin M Alexander, Yuxi Liu, Onyedika J Ilonze, C Michael Gibson, James L Januzzi
{"title":"Implications of Serum Transthyretin to NT-proBNP Ratio in Transthyretin Amyloid Cardiomyopathy: Insights From ATTRibute-CM.","authors":"Peder L Myhre, Gillian Murtagh, Hanna K Gaggin, Prem Soman, Mazen Hanna, Daniel P Judge, Ahmad Masri, Michel G Khouri, Emer Joyce, Kevin M Alexander, Yuxi Liu, Onyedika J Ilonze, C Michael Gibson, James L Januzzi","doi":"10.1016/j.jchf.2026.103493","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103493","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":"103493"},"PeriodicalIF":11.9,"publicationDate":"2026-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149170024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transpulmonary Gradient vs Pulmonary Vascular Resistance for Post-Transplant Risk Stratification. 经肺梯度与肺血管阻力对移植后风险分层的影响。
IF 11.9 1区 医学
JACC. Heart failure Pub Date : 2026-10-09 DOI: 10.1016/j.jchf.2026.103291
Ahmed A Zayed, Mathew Seplowe, Walid Sange, Bahy Abofrekha, Mohamad B Moumneh, Hadi Itani, Mohammad Ennab, Omar Khayat, Spencer Liu, Kenneth Dulnuan
{"title":"Transpulmonary Gradient vs Pulmonary Vascular Resistance for Post-Transplant Risk Stratification.","authors":"Ahmed A Zayed, Mathew Seplowe, Walid Sange, Bahy Abofrekha, Mohamad B Moumneh, Hadi Itani, Mohammad Ennab, Omar Khayat, Spencer Liu, Kenneth Dulnuan","doi":"10.1016/j.jchf.2026.103291","DOIUrl":"10.1016/j.jchf.2026.103291","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":"103291"},"PeriodicalIF":11.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149136783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence-Enabled Detection and Management of Physiological Instability in Heart Failure: Results of the Randomized LINK-HF2 Trial. 心力衰竭患者生理不稳定的人工智能检测和管理:随机LINK-HF2试验的结果
IF 11.9 1区 医学
JACC. Heart failure Pub Date : 2026-10-09 DOI: 10.1016/j.jchf.2026.103422
Konstantinos Sideris, Carsten Schmalfuss, Neil Lewis, Karim Sallam, Biykem Bozkurt, Thomas C Hanff, Michael T Young, Richard Schofield, Christos P Kyriakopoulos, Heather Hanson, Lina Brinker, Peter Wohlfahrt, Mandeep R Mehra, Tempa Curry, Cheri Knecht, Stephanie Tuckett, Richard E Nelson, Susan L Zickmund, Jorie M Butler, Jay M Edelberg, Gregory H Kurio, Stephan Wegerich, Stylianos Serghiou, Matt Pipke, Josef Stehlik
{"title":"Artificial Intelligence-Enabled Detection and Management of Physiological Instability in Heart Failure: Results of the Randomized LINK-HF2 Trial.","authors":"Konstantinos Sideris, Carsten Schmalfuss, Neil Lewis, Karim Sallam, Biykem Bozkurt, Thomas C Hanff, Michael T Young, Richard Schofield, Christos P Kyriakopoulos, Heather Hanson, Lina Brinker, Peter Wohlfahrt, Mandeep R Mehra, Tempa Curry, Cheri Knecht, Stephanie Tuckett, Richard E Nelson, Susan L Zickmund, Jorie M Butler, Jay M Edelberg, Gregory H Kurio, Stephan Wegerich, Stylianos Serghiou, Matt Pipke, Josef Stehlik","doi":"10.1016/j.jchf.2026.103422","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103422","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Artificial intelligence (AI)-enabled wearable monitoring can detect individualized physiological deviations preceding heart failure (HF) decompensation, but whether these signals can be translated into improved outcomes remains uncertain.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;This study aims to evaluate the feasibility of integrating AI-generated notifications with a structured clinician response algorithm into postdischarge HF care and to explore their association with HF events following hospitalization.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;LINK-HF2 (Detection of Physiological Anomaly Using Artificial Intelligence and Prevention of Heart Failure Hospitalization) was a prospective, randomized, open-label, blinded-endpoint study conducted at 5 Veterans Affairs medical centers. Adults hospitalized for acute HF were enrolled at discharge and assigned to AI-guided monitoring with clinician notification or to standard care. All participants wore a continuous multisensor patch for up to 90 days. A personalized similarity-based model detected deviations in cardiorespiratory and activity signals and generated notifications. Implementation outcomes included feasibility, acceptability, and usability. The main exploratory clinical endpoint was HF rehospitalization. Secondary exploratory clinical endpoints included the composite outcome of all-cause unplanned rehospitalizations, emergency department visits, and all-cause mortality. All clinical endpoints were compared through Cox proportional hazards models over the follow-up period.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among 171 analyzed participants, 80 (46.8%) were assigned to intervention and 91 (53.2%) to control. Median monitoring adherence was 72.4% of follow-up days; clinicians responded to communicated notifications within a median of 1 day (range: 1-5 days), and qualitative analysis demonstrated high patient acceptance and clinician engagement, whereas identifying workflow integration and response uncertainty as the primary barriers to implementation. In exploratory analyses, HF rehospitalization occurred in 13 (16.3%) patients in the intervention group and 17 (18.7%) in the control group (HR: 0.90, 95% CI: 0.43-1.84; P = 0.76). The composite clinical endpoint also did not differ between groups (HR 1.03; 95% CI: 0.63-1.70; P = 0.89). The intervention group had a lower rate of AI-detected physiological instability than controls (HR: 0.76; 95% CI: 0.60-0.97; P = 0.025).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;AI-enabled continuous physiological monitoring was feasible and reduced AI-detected physiological instability. Although this feasibility study did not demonstrate a reduction in exploratory clinical events, these findings highlight that accurate physiological risk detection alone may be insufficient to modify clinical risk without mechanistically aligned and trusted therapeutic responses. (Detection of Physiological Anomaly Using Artificial Intelligence and Prevention of Heart Fa","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":"103422"},"PeriodicalIF":11.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149136688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Failure With Improved Ejection Fraction: What Does "Improved" Mean in Women vs Men? 心力衰竭伴射血分数改善:女性与男性的“改善”是什么意思?
IF 11.9 1区 医学
JACC. Heart failure Pub Date : 2026-10-09 DOI: 10.1016/j.jchf.2026.103419
Carolyn S P Lam, Li Shen
{"title":"Heart Failure With Improved Ejection Fraction: What Does \"Improved\" Mean in Women vs Men?","authors":"Carolyn S P Lam, Li Shen","doi":"10.1016/j.jchf.2026.103419","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103419","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":"103419"},"PeriodicalIF":11.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Paced QRS to Assessing the Mechanical Substrate for Achieving Cardiac Resynchronization: A Leap of Faith or the Ground Truth? 从有节奏的QRS到评估实现心脏再同步化的机械基础:信念的飞跃还是基本的事实?
IF 11.9 1区 医学
JACC. Heart failure Pub Date : 2026-10-09 DOI: 10.1016/j.jchf.2026.103427
Sana M Al-Khatib, Jagmeet P Singh
{"title":"From the Paced QRS to Assessing the Mechanical Substrate for Achieving Cardiac Resynchronization: A Leap of Faith or the Ground Truth?","authors":"Sana M Al-Khatib, Jagmeet P Singh","doi":"10.1016/j.jchf.2026.103427","DOIUrl":"https://doi.org/10.1016/j.jchf.2026.103427","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":"103427"},"PeriodicalIF":11.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书